Discovery of novel 2,3-diarylfuro[2,3-b]pyridin-4-amines as potent and selective inhibitors of Lck: Synthesis, SAR, and pharmacokinetic properties.
Martin, M.W., Newcomb, J., Nunes, J.J., Bemis, J.E., McGowan, D.C., White, R.D., Buchanan, J.L., Dimauro, E.F., Boucher, C., Faust, T., Hsieh, F., Huang, X., Lee, J.H., Schneider, S., Turci, S.M., Zhu, X.(2007) Bioorg Med Chem Lett 17: 2299-2304
- PubMed: 17276681 
- DOI: https://doi.org/10.1016/j.bmcl.2007.01.048
- Primary Citation of Related Structures:  
2OF2, 2OF4 - PubMed Abstract: 
2,3-Diarylfuro[2,3-b]pyridine-4-amines are a novel class of potent and selective inhibitors of Lck. The discovery, synthesis, and structure activity relationships of this series of inhibitors are reported. The most promising compounds were also profiled to deduce their pharmacokinetic properties.
Organizational Affiliation: 
Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, MA 02139, USA. matmarti@amgen.com